Provides DNA/RNA data analysis and interpretation for WGS, WES, Gene Panels, and Microarrays. CE Marked.
Accelerates the diagnostic process from the raw genetic data to the clinical report
Provides Genomic and Clinical Cohort Analysis
Promotes a world with zero undiagnosed diseases

From NGS data analysis to drug discovery

Accelerating Genetic Diagnosis and Research

Geneyx Analysis

Geneyx Analysis

AI-Based Genetic Data Analysis and Interpretation Solution

Long Read Whole Genome sequencing

Long-Read Analysis

A PacBio and Oxford Nanopore compatible product


Integrating DNA and RNA Sequencing Data Analysis

Geneyx Clinical Apps

Ready-To-Use Apps: PGx, Carrier screening

Geneyx Data Training

High Quality Trained Data-Sets

Geneyx Among the World's Best Digital Health Companies in 2024

World’s Best

2024 Data Analysis Category

Cases Analyzed


Active Users






Success Stories

See Geneyx In Action

Towards Personalised Medicine for Breast Cancer in the Caribbean – A Pilot Study 

Dr. Weldon’s Caribbean Breast Cancer Whole Genome Pilot Study aims to identify unique genetic markers for Caribbean women that will allow for more specific predictive screening and earlier intervention.
Breast Cancer study using Geneyx Analysis

Detecting Uniparental disomy (UPD) with Geneyx Analysis

UPD occurs at a frequency of 1 in 2000 individuals worldwide (1). The most well-known conditions of UPD include Prader-Willi syndrome, characterized by binge-eating and obesity, and Angelman syndrome, which causes intellectual disability and impaired speech

Confirming Achromatopsia Diagnosis with Geneyx Analysis

One complex case they encountered was a female of Ethiopian descent that was diagnosed with achromatopsia. To confirm the clinical diagnosis, next-generation sequencing was performed. The fastq files were processed using the secondary pipeline integrated with Geneyx, and the VCF files were then annotated and analyzed using Geneyx Analysis.
Normal Retina and Retinal Achromatopsia
Woman Scientist

Applying Geneyx for high-throughput diagnostic settings

Implementation of Geneyx Analysis allowed customized gene panels with automatic reporting capabilities to easily accommodate for their large sample workflows. Coupled with this workflow automation, was the requirement to have customized reports. The Geneyx team was able to provide their customization requests to render reports using dynamic and static information

Identifying multi-nucleotide variants associated with congenital hypotonia and global developmental delay

WGS identified a likely pathogenic, de novo variant in POLR2A, which has a strong association with the phenotype displayed by the individual. The variant was adjacent to a polymorphism variant that was inherited from one of the parents, and this caused their in-house pipeline to mis-identify it as an inherited MNV in the exome sequencing analysis. The WGS findings led to a positive finding that could be presented to the patient.
Congenital Hypotonia


In Their Own Words

Schedule Demo

Contact us to set a live demo


Selected Videos

Geneyx Analysis Version 5.12 Release


Contact Us

Whether you have general questions about our solutions or would like to schedule a demo or to suggest collaboration – our team is on hand for you.